Ambagon Therapeutics
PrivateLast Round
Series A
Jan 6, 2022
Total Funding Raised
$103M
Company Overview
Ambagon Therapeutics is a biotechnology company that develops small-molecule cancer drugs by stabilizing the interaction of 14-3-3 proteins with oncogenic client proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ambagon Therapeutics Comparables
Compare Ambagon Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Magnet Biomedicine | 92% | |
| Plexium | 89% | |
| SEED Therapeutics | 88% | |
Ambagon Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 6, 2022 | ||||
| Seed | Jul 1, 2020 |
Key People
Founding team and executive leadership
Ambagon Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series A |
| RA Capital Management | Series A, Seed |
| Droia Ventures | Seed, Series A |
| BioInnovation Capital | Series A |
| AbbVie Ventures | Seed, Series A |
| Citadel | Series A |
| Inkef Capital | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 6, 2022
$85M round led by Nextech Invest.
- Jul 1, 2020
$18M round led by RA Capital Management.
Ambagon Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ambagon Therapeutics's valuation, stock price, and market status.